Action Statement on Heart Failure
A call to action outlining clear policy recommendations for European institutions to address the growing burden of heart failure.
Find out more
Heart failure policy and practice in Europe
Heart failure policy and practice in Europe aims to support advocates with clear outline of policy issues and best practice in heart failure across 11 European countries.
Find out more
Heart failure and health system sustainability
A European case study outlining how prioritising heart failure can help to build resilient and sustainable healthcare systems.
Find out more
heart graphic

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform of healthcare professionals, advocacy groups and policymakers from across Europe.

We aim to raise awareness of the unmet needs surrounding heart failure and its care, and to help drive meaningful changes in policy and practice.

Find out more
Latest
The HFPN Trailblazers Hub: supporting peer learning among heart failure advocates
19 October 2021

The Heart Failure Policy Network is delighted to announce the launch of the Trailblazers Hub, a new online resource showcasing examples of inspirational system transformation and political advocacy in heart failure.

Read article
Latest
Register now for the Heart Failure Policy Summit
5 October 2021

Join the Heart Failure Policy Network for the inaugural Heart Failure Policy Summit (16–18 November) – a new virtual event dedicated to the heart failure policy and advocacy community in Europe.

Read article
Latest
The HFPN and 27 organisations demand urgent EU action on heart failure
7 September 2021

The Heart Failure Policy Network has launched the Action Statement on Heart Failure, urging European institutions to address the growing burden of heart failure in the EU.

Read article
heart failure graphic
What is heart failure?

Affecting at least 15 million adults in Europe, heart failure is a common but complex clinical syndrome that occurs when the heart is unable to pump enough blood to meet body’s needs.

Its prevalence is expected to rise due to population ageing and improved survival rates for other long-term conditions, including cardiovascular diseases.

Find out more
The Heart Failure Policy Network is made possible with financial support from AstraZeneca, Vifor Pharma, Bayer AG, Boehringer Ingelheim and Novartis Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.